CSL - Trade Creditors

Stock Price
96.12
Daily Change
-1.84 -1.88%
Monthly
-30.05%
Yearly
-60.24%
Q2 Forecast
96.11

CSL reported $3.17B in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Arca Biopharma USD 4.16M 1.95M Dec/2025
aTyr Pharma USD 2.76M 52.32M Mar/2026
Bio Path USD 4.9M 1.42M Sep/2025
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Cara Therapeutics USD 3.22M 859K Dec/2025
CSL USD 3.17B 290M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
TherapeuticsMD USD 143K 4K Jun/2024